Suvretta Capital Management »

Immatics shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Immatics (IMTX) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Immatics

Tip: Access up to 7 years of quarterly data

All positions including Immatics held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immatics by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $11M 947k 11.62
2024-03-31 $9.9M 947k 10.51

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Biohaven (BHVN)
Insmed Com Par $.01 (INSM)
Kura Oncology (KURA)
Intra Cellular Therapies (ITCI)
Arcutis Biotherapeutics (ARQT)
Ultragenyx Pharmaceutical (RARE)
Meta Platforms Cl A (META)
Arcellx Common Stock (ACLX)
UnitedHealth (UNH)
Apple (AAPL)
Amazon (AMZN)
89bio (ETNB)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Advanced Micro Devices (AMD)

View all positions for Suvretta Capital Management

Top funds holding Immatics

Perceptive Advisors
T. Rowe Price Investment Management
Baker Bros. Advisors
Paradigm Biocapital Advisors
Vestal Point Capital
T. Rowe Price Associates
Woodline Partners
Citadel Advisors
OrbiMed Advisors
Goldman Sachs Group
RA Capital Management
Braidwell
Frazier Life Sciences Management
Suvretta Capital Management
Daniel D. Thurber

View all funds holding Immatics